Second-line Therapy

Summary

This study will help identify which ARV candidates should be prioritized for pediatric use in resource-limited settings

Conditions

• Treatment Failure of Second-line ART in Asian HIV-infected Children

Sponsors & Collaborators

• amfAR, The Foundation for AIDS Research

  collaborator OTHER

• Dr Cipto Mangunkusumo General Hospital

  collaborator OTHER

• Pediatric Institute, Hospital Kuala Lumpur

  collaborator UNKNOWN

• Chiang Mai University

  collaborator OTHER

• Srinagarind Hospital, Khon Kaen University

  collaborator OTHER

• Mahidol University

  collaborator OTHER

• Children's Hospital Number 1, Ho Chi Minh City, Vietnam

  collaborator OTHER

• Number 2 Children's Hospital, Ho Chi Minh City

  collaborator OTHER

• Kirby Institute

  collaborator OTHER_GOV

• University of California, San Francisco

  collaborator OTHER

• The HIV Netherlands Australia Thailand Research Collaboration

  lead OTHER

Principal Investigators

• Nia Kurniati, MD · Dr Cipto Mangunkusumo General Hospital

• Kamarul Razali, MD · Kuala Lumpur General Hospital

• Tavitiya Sudjaritruk, MD · Research Institute for Health Sciences, Chiang Mai University

• Pope Kosalaraksa, MD · Srinagarind Hospital, Khon Kaen Hospital

• Kulkanya Chokephaibulkit, MD · Siriraj Hospital

• Truong Huu Khanh, MD · Children's Hospital Number 1

• Do Chau Viet, MD · Children's Hospital Number 2

• Jintanat Ananworanich, MD, PhD · The HIV Netherlands Australia Thailand Research Collaboration

• Annette Sohn, MD · TREAT Asia

Eligibility

Max Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2011-01-31

Primary Completion

2015-07-31

Completion

2015-07-31

Countries

• Indonesia
• Malaysia
• Thailand
• Vietnam

Study Locations